Elisa D. Bal De Kier Joffe
Buenos Aires, C C1121ABG, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Comparative in vitro and in silico analysis of the ability of basic Asp49 phospholipase A2 and Lys49-phospholipase A2-like myotoxins from Bothrops diporus venom to inhibit the metastatic potential of murine mammary tumor cells and endothelial cell tubulogenesis: Asp49 vs Lys49 phospholipases A2: Inhibition of metastasis and angiogenesis.
Journal: Chemico-biological interactions
Published: April 10, 2024
N4 -aryl substituted thiosemicarbazones derived from 1-indanones as potential anti-tumor agents for breast cancer treatment.
Journal: Journal of cellular physiology
Published: August 08, 2017
Therapeutic blockade of Foxp3 in experimental breast cancer models.
Journal: Breast cancer research and treatment
Published: June 01, 2017
Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture.
Journal: Journal of cellular biochemistry
Published: March 21, 2017
The Immune System As a New Possible Cell Target for AFP 464 in a Spontaneous Mammary Cancer Mouse Model.
Journal: Journal of cellular biochemistry
Published: January 26, 2017
The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines.
Journal: Cancer cell international
Published: September 17, 2016
Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.
Journal: Journal of cancer research and clinical oncology
Published: April 30, 2016
Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Journal: Oncotarget
Published: September 18, 2015
Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 14, 2015
Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.
Journal: Oncogene
Published: April 24, 2015
Last Updated: 09/26/2026